A new prostate cancer treatment to improve outcomes and reduce side-effects
Ended Cooperative Agreement Awarded Last action
- Award ID
- R41CA210737
- Recipient
-
Pxalpha, L.L.C. UEI F7JGTSJC19E9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Coralville, IA 52241, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $225,000 |
Quick answers
Who received award R41CA210737?
R41CA210737 was awarded to Pxalpha, L.L.C. by National Cancer Institute (National Institutes of Health) on September 15, 2016.
How much is award R41CA210737 worth?
$225,000 has been obligated on R41CA210737.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award